Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Alliance Pharma names Camillo Pane as chair

(Sharecast News) - Consumer healthcare company Alliance Pharma has appointed Camillo Pane to the role of chairman to "lead the company through its next strategic phase", focusing on organic growth through marketing and innovation. Alliance Pharma said on Monday that Pane will take over as chairman on 19 February following a handover period from outgoing chair Jo LeCouilliard.

The AIM-listed group highlighted that Panillo has over thirty years' of experience in US, European, and Asian public, multinational consumer companies. During his career, Pane has held a number of senior positions at Reckitt Benckiser, where he spent almost 20 years across both global and regional roles. Most recently, he was group CEO of Health & Happiness Group, a global health and nutrition company listed on the Hong Kong Stock Exchange with revenues of around $2.0bn.

Senior independent director Richard Jones said: "On behalf of the Alliance Board and the company I would like to thank Jo for her significant contribution to Alliance over the past five years and wish her well for the future. We look forward to Camillo joining the board as chair and harnessing his wide-ranging consumer healthcare experience to further enhance and develop our group strategy. In the meantime, the board remains focused on creating value for our shareholders by investing in growth whilst carefully managing our cost base."

As of 0905 GMT, Alliance Pharma shares were up 2.30% at 40.05p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

ECR Minerals mulls expansion into US helium market
(Sharecast News) - ECR Minerals, an exploration and development company traditionally focused on gold in Australia, announced on Friday that its board was exploring potential investments in producing helium assets in the United States.
Zenova reports solid momentum as interim loss narrows
(Sharecast News) - Fire safety and heat management technology specialist Zenova Group reported significant first-half strides in its interim results on Friday, despite a challenging financial backdrop.
Jefferies lowers target price on Life Science REIT
(Sharecast News) - Jefferies cut its price target on real estate investment trust Life Sciences REIT from 45.0p to 36.0p following a visit to the group's Cambourne Science & Technology Park.
Beowulf reports substantial first-half progress
(Sharecast News) - Mineral explorer and developer Beowulf Mining reported substantial progress across its portfolio in its interim results on Friday, particularly in advancing its key projects at Gállok in Sweden and the Graphite Anode Materials Plant (GAMP) in Finland.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.